US pharma giant Pfizer has committed $500 million to expand its gene therapy by constructing a new gene therapy manufacturing facility in Sanford in North Carolina.
Pfizer’s Sanford gene therapy facility will expand the company’s manufacturing footprint in North Carolina and help advance production of one-time gene therapies that use custom-made recombinant adeno-associated virus (rAAV) vectors.
The gene therapy manufacturing facility in Sanford will also produce components for the company’s several vaccines such as Prevenar 13, which are currently in research pipeline. The expanded gene therapy facility is estimated to create nearly 300 new jobs.
Pfizer to invest $500m to construct new gene therapy manufacturing facility in Sanford. Photo courtesy of w:ru:jenix89 (talk | contribs) and Wikipedia.org.
Angela Hwang – president of Pfizer Biopharmaceuticals Group, commenting on the new Pfizer gene therapy manufacturing facility in Sanford, said: “We’re excited to build this new state-of-the-art facility in Sanford because it will have the potential to help us develop novel methods to deliver transformative treatments to patients.”
The company’s other North Carolina research and development sites include Chapel Hill and Kit Creek.
Commenting on the Sanford gene therapy facility, Mike McDermott – president of Pfizer Global Supply said: “This investment will further strengthen Pfizer’s leadership in gene therapy manufacturing technology.
“The expansion of the Sanford site is expected to create hundreds of highly skilled jobs, which would increase Sanford’s high-tech manufacturing environment and is part of our overall plan to invest approximately $5 billion in U.S.-based capital projects over the next several years.”
Scientists at Kit Creek facility work at a small scale – from 2L flasks up to 250L bioreactors – to develop the manufacturing process that is optimized by the Chapel Hill facility colleagues who continue to work at a 250L scale.
For more pharma industry news and updates on Pfizer gene therapy manufacturing facility in Sanford, keep following Pharma News Daily.
Related posts
The post Pfizer to build $500m gene therapy manufacturing facility in Sanford appeared first on PharmaNewsDaily.com.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.